{"id":153577,"date":"2017-10-19T10:35:02","date_gmt":"2017-10-19T10:35:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=153577"},"modified":"2017-10-19T10:35:02","modified_gmt":"2017-10-19T10:35:02","slug":"intravenous-immunoglobulin-market-by-guillainbarre-syndrome-kawasaki-disease-itp-and-forecasts-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/intravenous-immunoglobulin-market-by-guillainbarre-syndrome-kawasaki-disease-itp-and-forecasts-to-2023_153577.html","title":{"rendered":"Intravenous Immunoglobulin Market by Guillain-Barre Syndrome, Kawasaki Disease, ITP and Forecasts to 2023"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/10\/1508265860.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/10\/1508265860.jpeg\" alt=\"\" width=\"225\" height=\"246\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Market Research Future&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Global Intravenous Immunoglobulin Market report provides in-depth analysis of key players and their strategic profiling in the market. The research report provides comprehensive analysis of their core competencies.<\/div>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">The World Intravenous Immunoglobulin Market is growing at the CAGR of ~5.9% during the forecast period and expected to reach US$ 8337.2 million by 2023.<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">The Global <strong><em><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/reports\/intravenous-immunoglobulin-market-3137\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/reports\/intravenous-immunoglobulin-market-3137\">Intravenous Immunoglobulin Market<\/a><\/em><\/strong> is growing moderately. IVIg is concerned with the treatment of patients who have weak immune system. Globally the market for Intravenous Immunoglobulin is increasing rapidly the main reason for this is rapidly increasing population. The World Intravenous Immunoglobulin Market report analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Intravenous Immunoglobulin Industry.<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Key Players for Global Intravenous Immunoglobulin (IVIg) Market:<\/span><\/span><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\"> ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland) and others.<\/span><\/span><\/p>\n<p><strong><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Get Sample Copy @ <\/span><\/span><\/em><\/strong><em><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/3137\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/3137\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">https:\/\/www.marketresearchfuture.com\/sample_request\/3137<\/span><\/span><\/a><\/em><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\"> .<\/span><\/span><\/em><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Human body produces enough antibodies to fight infection causing germs, but if patients is suffering from immune deficiency then body can&rsquo;t produce enough of them. The increasing demand for alternate immunoglobulin replacement therapies, new innovations, increasing R&amp;D funding, developing healthcare infrastructure and increasing healthcare expenditure are major driving forces of the market.<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Regional Analysis of Global Intravenous Immunoglobulin (IVIg) Market:<\/span><\/span><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Considering the global scenario of the market, North America is believed to be the largest market for Global IVIg. Moreover the European market, especially Western Europe is growing and second largest market for Global IVIg. On the other hand, Asia-Pacific is expected to grow at significant rate in the Global IVIg market during the forecasted period. Middle East and Africa is likely to have a limited but steady growth in the market, particularly market in North Africa is growing as compared to South and East region of Africa due to less awareness of these therapies and treatment. <\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Global Intravenous Immunoglobulin (IVIg) Market has been segmented on the basis of type which comprise IgA (sub segments- IgA1 and IgA2), IgD, IgE, IgG,. On the basis of application it segmented into CIDP (Progressive, Recurrent, Monophasic), Hypogammaglobulinemia (sub segments- AGM1, AGM2, AGM3, AGM4, AGM5, AGM6), Multifocal Motor Neuropathy, Immunodeficiency diseases (sub segments- X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), severe combined immunodeficiency), Primary Humoral Immunodeficiency (Subsegments- B cell (antibody) deficiencies, T cell deficiencies, Combination B and T cell deficiencies, Defective phagocytes, Complement deficiencies, Unknown (idiopathic)), Myasthenia Gravis (Sub segments- generalized myasthenia gravis, ocular myasthenia gravis, Congenital myasthenia gravis, Transient neonatal myasthenia gravis), Guillain-Barre syndrome (Sub segments- Acute inflammatory demyelinating polyradiculoneuropathy (AIDP), Miller Fisher syndrome (MFS), Acute motor axonal neuropathy (AMAN)and acute motor-sensory axonal neuropathy (AMSAN)), Kawasaki disease, ITP (Sub segments- acute and chronic), and others.<\/span><\/span><\/p>\n<p><strong><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Get Discount @<\/span><\/span><\/em><\/strong><em> <a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/check-discount\/3137\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/check-discount\/3137\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">https:\/\/www.marketresearchfuture.com\/check-discount\/3137<\/span><\/span><\/a><\/em><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\"> .<\/span><\/span><\/em><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Major TOC Intravenous Immunoglobulin Market:<\/span><\/span><\/strong><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Research methodology<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Market dynamics<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Market factor analysis<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Global Intravenous Immunoglobulin market, by types<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Global Intravenous Immunoglobulin market, by segmentation <\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Global Intravenous Immunoglobulin market, by application<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Global Intravenous Immunoglobulin market, by region<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Competitive landscape<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Company profile<\/span><\/span><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">About US:<\/span><\/span><\/strong><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &amp; Consulting Services.<\/span><\/span><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Contact Us:<\/span><\/span><\/strong><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Akash Anand,<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Market Research Future<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Office No. 528, Amanora Chambers<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Magarpatta Road, Hadapsar,<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Pune &#8211; 411028<\/span><\/span><\/p>\n<p><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Maharashtra, India<\/span><\/span><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Phone: <\/span><\/span><\/strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">+1 646 845 9312<\/span><\/span><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\">Email:<\/span><\/span><\/strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana','sans-serif';\"> akash.anand@marketresearchfuture.com<\/span><\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Market Research Future<br \/><strong>Contact Person:<\/strong> Akash Anand<br \/><strong>Email:<\/strong> akash.anand@marketresearchfuture.com<br \/><strong>Phone:<\/strong> +1 646 845 9312<br \/><strong>Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune &#8211;   <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketresearchfuture.com\/reports\/intravenous-immunoglobulin-market-3137\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketresearchfuture.com\/reports\/intravenous-immunoglobulin-market-3137<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketresearchfuture.com\/reports\/intravenous-immunoglobulin-market-3137\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=intravenous-immunoglobulin-market-by-guillainbarre-syndrome-kawasaki-disease-itp-and-forecasts-to-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Market Research Future&#8221; The Global Intravenous Immunoglobulin Market report provides in-depth analysis of key players and their strategic profiling in the market. The research report provides comprehensive analysis of their core competencies. The World Intravenous Immunoglobulin Market is growing at &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/intravenous-immunoglobulin-market-by-guillainbarre-syndrome-kawasaki-disease-itp-and-forecasts-to-2023_153577.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-153577","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/153577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=153577"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/153577\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=153577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=153577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=153577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}